MarcLPeters-GoldenMD

Critical Care Medicine, Pleural Disease

Professor, Internal Medicine, University of Michigan Medical School

Dr. Peters-Golden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1500 East Medical Center Dr
3rd Floor Taubman Ctr Recp C
Ann Arbor, MI 48109
Phone+1 734-647-9342

Fax+1 734-615-5348

Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1981 - 1984
Tufts Medical CenterResidency, Internal Medicine, 1978 - 1981
Duke University School of MedicineClass of 1978

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Elected Member The American Society for Clinical Investigation, 1996

PubMed

75 citations
The Induction of Pro-IL-1β by Lipopolysaccharide Requires Endogenous Prostaglandin E2 Production.
Zbigniew Zaslona, Eva M. Palsson-McDermott, Deepthi Menon, Moritz Haneklaus, Ewelina Flis
Journal of Immunology. 2017-03-15
98 citations
Reversal of Myofibroblast Differentiation by Prostaglandin E2
Garth Garrison, Steven K. Huang, Katsuhide Okunishi, Jacob P. Scott, Loka R. Penke
American Journal of Respiratory Cell and Molecular Biology. 2013-05-01
81 citations
PGE2 inhibition of TGF-β1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling
Peedikayil E. Thomas, Marc Peters-Golden, Eric S. White, Victor J. Thannickal, Bethany B. Moore
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2007-08-01

Prostanoids, Plasminogen Actication, And Personalized Therapeutics In IPFNational Heart, Lung, And Blood Institute2011
Control Of Fibroblast Function By Prostaglandin E2 And Plasminogen ActivationNational Heart, Lung, And Blood Institute2009–2011
Eicosanoids And Lung Macrophage Antimicrobial MechanismsNational Heart, Lung, And Blood Institute2000–2011
Eicosanoids And Lung Macrophage Antimicrobial MechanismsNational Heart, Lung, And Blood Institute2008
Eisosanoid Imbalance In Fibrotic Lung DiseaseNational Heart, Lung, And Blood Institute2002–2005
Deficient Cyclooxygenase Expression In IPF FibroblastsNational Heart, Lung, And Blood Institute1997–2001
Leukotrienes And Pulmonary Antibacterial DefenseNational Heart, Lung, And Blood Institute1997–1999
Molecular Regulation Of Macrophage 5-LipoxygenaseNational Heart, Lung, And Blood Institute1992–1995
Determinants Of Lung Macrophage Arachidonate MetabolismNational Heart, Lung, And Blood Institute1986–1990